Ana Catalina "Cata" Arce-Clachar, MD

Topiramate treatment of pediatric metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study. Kohut, T; Tou, A; Carr, E; Xanthakos, S; Arce-Clachar, AC; Fawaz, R; Valentino, PL; Panganiban, J; Mouzaki, M. Journal of Parenteral and Enteral Nutrition. 2025; 49:308-313.

Least significant change with repeat bioelectrical impedance analysis measurements in children with metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study. Speakman, A; Hitchcock, K; Romantic, E; Quiambao, V; Lepolt, A; Arce-Clachar, AC; Bramlage, K; Fei, L; Sun, Q; Xanthakos, S; Mouzaki, M. Journal of Parenteral and Enteral Nutrition. 2025; 49:200-206.

Longitudinal Links between Changes in Body Composition and Liver Disease Severity in Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Liver Disease. Speakman, A; Hitchcock, K; Romantic, E; Quiambao, V; Lepolt, A; Ley, S; Arce-Clachar, AC; Bramlage, K; Fei, L; Sun, Q; Xanthakos, S; Mouzaki, M. The Journal of Pediatrics. 2025; 276:114301.

Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severity. Mouzaki, M; Yates, KP; Arce-Clachar, AC; Behling, C; Blondet, NM; Fishbein, MH; Flores, F; Adams, KH; Hertel, P; Jain, AK; Molleston, JP; Schwimmer, JB; Vos, MB; Xanthakos, SA. Journal of Pediatric Gastroenterology and Nutrition. 2024; 79:238-249.

Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease. Wang, A; Blackford, AL; Behling, C; Wilson, LA; Newton, KP; Xanthakos, SA; Fishbein, MH; Vos, MB; Mouzaki, M; Molleston, JP; Wagoner, A; Wilson, LA; Woreta, T; Yates, KP. Hepatology. 2024; 79:1381-1392.

Food Insecurity and Pediatric Nonalcoholic Fatty Liver Disease Severity. Orkin, S; Zhao, X; Setchell, KD R; Carr, E; Arce-Clachar, AC; Bramlage, K; Huang, R; Fei, L; Beck, AF; Fawaz, R; Valentino, PL; Xanthakos, SA; Mouzaki, M. The Journal of Pediatrics. 2024; 265:113818.

Development and Implementation of a Multidisciplinary Clinic Focused on the Care of Adolescents with Youth-Onset Type 2 Diabetes. Schaaf, L; Ley, S; Riegler, A; Poetker, A; Xanthakos, S; Sizemore, J; Crimmins, N; Helmrath, M; Tracy, R; Arce-Clachar, AC; Crail, J; Morwessel, N; Frenck, K; Tariq, F; Shah, AS. Journal of Multidisciplinary Healthcare. 2023; 16:2799-2807.

Nutrition assessment and MASH severity in children using the Healthy Eating Index. Jain, AK; Buchannan, P; Yates, KP; Belt, P; Schwimmer, JB; Rosenthal, P; Murray, KF; Molleston, JP; Scheimann, A; Xanthakos, SA; Boyett, S; Contos, MJ; Luketic, VA C; Sanyal, AJ. Hepatology Communications. 2023; 7:e0320.

Clinical Performance of Transient Elastography With Comparison to Quantitative Magnetic Resonance Imaging, Ultrasound, and Biopsy in Children and Adolescents With Known or Suspected Fatty Liver Disease. Alves, VP V; Trout, AT; Dewit, M; Mouzaki, M; Arce-Clachar, AC; Bramlage, KS; Dillman, JR; Xanthakos, SA. Childhood Obesity. 2023; 19:461-469.

Presence of Alpha 1 Antitrypsin Risk Variants is Not Associated With Histologic Severity of Pediatric NAFLD. Khan, M; Klepper, C; Orkin, S; Arce-Clachar, AC; Bramlage, K; Fei, L; Miethke, A; Kohli, R; Xanthakos, S; Mouzaki, M. Journal of Pediatric Gastroenterology and Nutrition. 2023; 77:166-170.